Braintree Laboratories
Clinical trials sponsored by Braintree Laboratories, explained in plain language.
-
New pill aims to heal Acid-Damaged esophagus
Disease control CompletedThis study tested a new drug called BLI5100 in 1250 adults with erosive esophagitis, a condition where stomach acid damages the esophagus. Participants took either BLI5100 or a standard PPI (proton pump inhibitor) daily for up to 8 weeks to see if it healed the damage, then for 2…
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
GERD drug BLI5100 passes Year-Long safety check
Disease control CompletedThis study checked the safety of taking BLI5100 daily for up to 12 months in 400 adults with gastroesophageal reflux disease (GERD). Participants had either non-erosive reflux disease or healed erosive esophagitis. The main goal was to track any side effects. This is a disease co…
Phase: PHASE3 • Sponsor: Braintree Laboratories • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC